HRL Holdings Ltd operates in the Testing laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares HRL Holdings Ltd with three other
miscellaneous service companies in Australasia:
sales of 35.36 million Australian Dollars [US$25.02 million]
of which 89%
was Clinical Trials),
Site Group International Limited
(27.26 million Australian Dollars [US$19.29 million]
Clinuvel Pharmaceuticals Limited
(33.13 million Australian Dollars [US$23.45 million]
of which 100%
HRL Holdings Ltd reported sales of A$32.81 million (US$23.22 million)
June of 2020.
increase of 6.8%
versus 2019, when the company's sales were A$30.73 million.
Sales at HRL Holdings Ltd have increased during each of the previous five years
(and since 2015, sales have increased a total of 603%).
Sales of Software saw an increase
that was more than double the company's growth rate: sales were up
20.9% in 2020, from
A$734,632.00 to A$888,148.00 .
HRL Holdings Ltd also saw significant increases in sales in
Food/environment Laboratory (up 15.6% to A$16.42 million)
Hazmat (up 11.6% to A$8.67 million)
Not all segments of HRL Holdings Ltd experienced an increase in sales in 2020:
sales of Geotechnical fell 15.0% to A$6.83 million.